Dulbecco Telethon laboratorio di prioni e amiloidi

Biasini E, Faccioli P. Functional, Pathogenic, and Pharmacological Roles of Protein Folding Intermediates. Proteins. 2023 Feb 13. doi: 10.1002/prot.26479. 
https://pubmed.ncbi.nlm.nih.gov/36779817

Spagnolli G, Massignan T, et al. Pharmacological inactivation of the prion protein by targeting a folding intermediate. Commun Biol. 2021 Jan 12;4(1):62. doi: 10.1038/s42003-020-01585-x. 
https://pubmed.ncbi.nlm.nih.gov/33437023

Manni G, Lewis V, Senesi M, Spagnolli G, Fallarino F, Collins SJ, Mouillet-Richard S, Biasini E. The cellular prion protein beyond prion diseases. Swiss Med Wkly. 2020 Apr 24;150:w20222. doi: 10.4414/smw.2020.20222. 
https://pubmed.ncbi.nlm.nih.gov/32330284

Spagnolli G, Rigoli M, Orioli S, Sevillano AM, Faccioli P, Wille H, Biasini E & Requena JR. Full atomistic model of prion structure and conversion. PLoS Pathog. 2019 Jul 11;15(7):e1007864. doi: 10.1371/journal.ppat.1007864.
https://pubmed.ncbi.nlm.nih.gov/31295325

Rigoli M, Spagnolli G, Faccioli P, Requena JR & Biasini E. Ok Google, how could I design therapeutics against prion diseases? Curr Opin Pharmacol. 2019 May 3;44:39-45. doi: 10.1016/j.coph.2019.03.015. 
https://pubmed.ncbi.nlm.nih.gov/31059982

Biasini E. A designer chaperone against prion diseases. Nat Biomed Eng. 2019 Mar;3(3):167-168. doi: 10.1038/s41551-019-0367-6.
https://pubmed.ncbi.nlm.nih.gov/30948815

  • Emiliano Biasini, Professore Associato
  • Sacha Genovesi, Lab Manager
  • Alessandra Pasotto, Technician
  • Ilaria Zeni, Collaboratrice di ricerca
  • Nicole Innocenti, Collaboratrice di ricerca
  • Andrea Dallapè, Collaboratore di ricerca
  • Giorgia Giovannini, Ricercatrice Marie Curie
  • Dino Gasparotto, Dottorando
  • Elisa Nicolini,  Dottoranda
  • Almog Levi, Dottorando
  • Chiara Vecchi, Dottoranda
  • Annarita Zanon, Dottoranda Visiting
  • Daniele Sovilla, Studente magistrale
  • Laura Carlesso, Studentessa magistrale
  • Matteo Bisigato, Studente magistrale
  • Rafaela Germano, Studentessa magistrale
  • Ines Mancini, Graziano Lolli, Alberto Inga, Yari Ciribilli, Alvise Berti, University of Trento, ITALY
  • Pietro Faccioli, University of Milano-Bicocca, ITALY
  • Maria Letizia Barreca, Giuseppe Manfroni & Francesca Fallarino, University of Perugia, ITALY
  • Jesús R. Requena, University of Santiago de Compostela, SPAIN
  • Romolo Nonno, Ilaria Vanni, Istituto Superiore di Sanità, ITALY
  • Pietro Roversi, CNR, ITALY
  • Giovanni Nardo, Valentina Bonetto, Roberto Chiesa, Mario Negri Institute in Milan, ITALY
  • Roman Polishchuk, TIGEM, ITALY
  • Sophie Mouillet-Richard, Centre de Recherche des Cordeliers, FRANCE
  • SpacePharma r&d, ISRAEL
  • Sibylla Biotech S.p.A., ITALY
  • CASRevolution S.R.L., ITALY
  • KLISBio S.R.L., ITALY